Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial
収録刊行物
-
- The Lancet Infectious Diseases
-
The Lancet Infectious Diseases 21 (12), 1654-1664, 2021-12
Elsevier BV